Influence of the HLA class II polymorphism in chronic Chagas' disease

被引:0
|
作者
Fernandez-Mestre, MT
Layrisse, Z
Montagnani, S
Acquatella, H
Catalioti, F
Matos, M
Balbas, O
Makhatadze, N
Dominguez, E
Herrera, F
Madrigal, A
机构
[1] Inst Venezolano Invest Cient, Ctr Med Expt, Caracas 1020A, Venezuela
[2] Ctr Invest Jose Francisco Torrealba, San Juan Morros, Venezuela
[3] Anthony Nolan Res Inst, London, England
关键词
MHC; HLA; DNA typing; Chagas' disease;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chagas' disease or American trypanosomiasis due to Trypanosoma cruzi has existed at least since the time of the Inca empire and contributes significantly to cardiovascular morbidity and mortality in several countries of this continent. Due to the fundamental role of human class II molecules polymorphic residues in the control of the immune response, a study was designed to define by DNA typing HLA class II alleles in a sample of 67 serologically positive individuals with and without cardiomyopathy and in 156 healthy controls of similar ethnic origin. Genomic DNA extraction, PCR amplification of the HLA-DRB1 and DQB1 second exon regions and hybridization to labelled specific probes were carried outfollowing the 11th International Histocompatibility Workshop reference protocol. Comparison of DRB1 and DQB1 allele frequencies among the patients and control subjects showed a decreased frequency of DRB1*14 and DeB1*0303 in the patients, suggesting independent protective effects to the chronic infection in this population. Allele frequencies comparison between patients with and without cardiomyopathy showed a higher frequency of DRB1*01, DRB1*08 and DQB1*0501 and a decreased frequency of DRB1*1501 in the patients with arrhitmia and congestive heart failure. The results suggest that HLA Class II genes may be associated with the development of a chronic infection and with heart damage in Chagas' disease.
引用
收藏
页码:197 / 203
页数:7
相关论文
共 50 条
  • [1] HLA class II polymorphism in chronic Chagas disease.
    Fernandez, M
    Layrisse, Z
    Montagnani, S
    Acquatella, H
    Catalioti, F
    Matos, M
    Balbas, O
    Makhatadze, N
    Dominguez, E
    Herrera, F
    Madrigal, A
    HUMAN IMMUNOLOGY, 1997, 55 : 55 - 55
  • [2] HLA Class I and II Profiles of Patients Presenting with Chagas' Disease
    N. H. S. Deghaide
    R. O. Dantas
    E. A. Donadi
    Digestive Diseases and Sciences, 1998, 43 : 246 - 252
  • [3] HLA class I and II profiles of patients presenting with Chagas' disease
    Deghaide, NHS
    Dantas, RO
    Donadi, EA
    DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (02) : 246 - 252
  • [4] HLA class II polymorphism in children with celiac disease in Tunisia
    Laadhar, L.
    Toumi, A.
    Kallel-Sellami, M.
    Ben Hariz, M.
    Zitouni, M.
    Mehrezi, A.
    Makni, S.
    TISSUE ANTIGENS, 2007, 69 (05): : 474 - 475
  • [5] HLA class II polymorphism in children with coeliac disease in Tunisia: is there any influence on clinical manifestation?
    Laadhar, Lilia
    Toumi, Amina
    Kallel-Sellami, Maryam
    Zitouni, Mondher
    Bouraoui, Saadia
    Maherzi, Ahmed
    Makni, Sondes
    Hariz, Mongi Ben
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (11) : 1286 - 1290
  • [6] Immunogenetics of HLA class II polymorphism on the susceptibility to periodontal disease.
    Ohyama, H
    JOURNAL OF DENTAL RESEARCH, 2001, 80 (04) : 1323 - 1323
  • [7] HLA class II polymorphism and AIDS progression
    Gao, X
    Marti, D
    Karacki, P
    Vlahov, D
    Goedert, J
    Kaslow, R
    Buchbinder, S
    Hoots, K
    O'Brien, S
    Carrington, M
    TISSUE ANTIGENS, 2002, 59 : 67 - 67
  • [8] HLA class II polymorphism in the North of France
    Fajardy, I
    Damien, E
    Lourme, C
    Danze, PM
    HUMAN IMMUNOLOGY, 1996, 47 (1-2) : P274 - P274
  • [9] HLA CLASS-II DR GENE POLYMORPHISM IN GRAVES-DISEASE
    SHEPPARD, M
    SIDDIQI, S
    FRANKLYN, J
    YOUNG, E
    FLETCHER, J
    ANNALES D ENDOCRINOLOGIE, 1987, 48 (02) : 125 - 125
  • [10] Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease
    Fogdell-Hahn, A
    Ligers, A
    Gronning, M
    Hillert, J
    Olerup, O
    TISSUE ANTIGENS, 2000, 55 (02): : 140 - 148